DOSE MODIFICATION REDUCES THE INCIDENCE OF HIGH-DOSE ARA-C (HDAC) NEUROTOXICITY IN PATIENTS WITH RENAL-INSUFFICIENCY

被引：0
|
作者：
SMITH, G [1 ]
DAMON, L [1 ]
RUGO, H [1 ]
RIES, C [1 ]
LINKER, C [1 ]
机构：
[1] UNIV CALIF SAN FRANCISCO,DIV HEMATOL,SAN FRANCISCO,CA 94143
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A146 / A146
页数：1
相关论文
共 50 条
  • [41] PHARMACOLOGICAL BASIS FOR THE THERAPEUTIC INDEX OF HIGH-DOSE ARA-C - IMPLICATIONS FOR COMBINATIONS
    PLUNKETT, W
    ADAMS, T
    KEATING, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 174 - 174
  • [42] HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN COLORECTAL-CANCER
    KANOJIA, M
    KANTARJIAN, H
    AJANI, J
    BARLOGIE, B
    BRITISH JOURNAL OF CANCER, 1983, 48 (06) : 869 - 871
  • [43] MODULATION OF THE CELLULAR PHARMACOLOGY OF HIGH-DOSE ARA-C (HIDAC) BY ASPARAGINASE (ASNASE)
    WANG, LM
    CAPIZZI, RL
    WHITE, C
    CONTENTO, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 409 - 409
  • [44] HIGH-DOSE ARA-C AND ETOPOSIDE IN REFRACTORY OR RELAPSING ACUTE-LEUKEMIA
    FREUND, M
    LINK, H
    DIEDRICH, H
    LEBLANC, S
    WILKE, HJ
    POLIWODA, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (06) : 487 - 490
  • [45] A Randomized Comparison of Modified Intermediate-dose Ara-C versus High-dose Ara-C in Post-remission Therapy for Acute Myeloid Leukemia
    Fukushima, Toshihiro
    Urasaki, Yoshimasa
    Yamaguchi, Masaki
    Ueda, Mikio
    Morinaga, Koji
    Haba, Toshihiro
    Sugiyama, Toshiro
    Nakao, Shinji
    Origasa, Hideki
    Umehara, Hisanori
    Ueda, Takanori
    ANTICANCER RESEARCH, 2012, 32 (02) : 643 - 647
  • [46] PHARMACOKINETICS OF HIGH-DOSE ARA-C (HIDAC) - A PHARMACOLOGIC MEANS FOR SELF POTENTIATION
    CAPIZZI, RL
    YANG, JL
    CHENG, E
    SAHASRABUDHE, D
    TAN, RS
    CHENG, YC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 130 - 130
  • [47] CLINICAL-EXPERIENCE WITH HIGH-DOSE ARA-C AND L-ASP
    DICKERHOFF, R
    HAAS, RJ
    ONKOLOGIE, 1985, 8 (01): : 44 - 45
  • [48] ALTERATION OF THE PHARMACOKINETICS OF HIGH-DOSE ARA-C BY ITS METABOLITE, HIGH ARA-U IN PATIENTS WITH ACUTE-LEUKEMIA
    CAPIZZI, RL
    YANG, JL
    CHENG, E
    BJORNSSON, T
    SAHASRABUDHE, D
    TAN, RS
    CHENG, YC
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) : 763 - 771
  • [49] DOSE-RELATED PHARMACOLOGIC EFFECTS OF HIGH-DOSE ARA-C AND ITS SELF-POTENTIATION
    CAPIZZI, RL
    YANG, JI
    RATHMELL, JP
    WHITE, JC
    CHENG, E
    CHENG, YC
    KUTE, T
    SEMINARS IN ONCOLOGY, 1985, 12 (02) : 65 - 75
  • [50] Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity
    S Mineishi
    WL Longo
    ME Atkinson
    EP Smith
    M Hamielec
    SR Wiersma
    TJ Kinsella
    FG Schuening
    Bone Marrow Transplantation, 1999, 23 : 1217 - 1222
12345